Novel Regimen Boosts Survival for Recurrent Platinum-Resistant Ovarian Cancer

(MedPage Today) -- SAN JUAN, PUERTO RICO -- A novel regimen for platinum-resistant ovarian cancer solidified its role as a treatment option with a significant improvement in overall survival (OS), according to a ROSELLA trial update. Adding...
Source
MedPage Today
Opens original article in a new tab



